Gan & Lee Pharmaceuticals. (SHA:603087)
60.14
+0.16 (0.27%)
May 8, 2026, 3:00 PM CST
SHA:603087 Market Cap
SHA:603087 has a market cap or net worth of 35.8 billion as of May 8, 2026. Its market cap has increased by 41.66% in one year.
Market Cap
35.80B
Enterprise Value
32.39B
Revenue
3.95B
Ranking
n/a
PE Ratio
34.72
Stock Price
60.14
Market Cap Chart
Since June 29, 2020, SHA:603087's market cap has decreased from 36.57B to 35.80B, a decrease of -2.12%. That is a compound annual growth rate of -0.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 35.80B | -11.65% |
| Dec 31, 2025 | 40.52B | 53.87% |
| Dec 31, 2024 | 26.33B | -15.24% |
| Dec 29, 2023 | 31.07B | 68.57% |
| Dec 30, 2022 | 18.43B | -53.34% |
| Dec 31, 2021 | 39.50B | -46.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Imeik Technology Development | 35.25B |
| Intco Medical Technology | 33.94B |
| Andon Health | 31.86B |
| iRay Group | 24.96B |
| Zhende Medical | 24.66B |
| Winner Medical | 18.59B |
| Shenyang Xingqi Pharmaceutical | 17.09B |
| Micro-Tech (Nanjing) Co.,Ltd | 15.57B |